Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Operating Margin over the past 16 years, most recently at 14.62% for Q2 2025.

  • Quarterly results put Operating Margin at 14.62% for Q2 2025, up 894.0% from a year ago — trailing twelve months through May 2025 was 13.38% (down 649.0% YoY), and the annual figure for FY2025 was 13.38%, down 649.0%.
  • Operating Margin for Q2 2025 was 14.62% at Lifecore Biomedical, Inc. \De\, up from 25.68% in the prior quarter.
  • Over the last five years, Operating Margin for LFCR hit a ceiling of 14.62% in Q2 2025 and a floor of 46.89% in Q3 2024.
  • Median Operating Margin over the past 5 years was 14.28% (2021), compared with a mean of 13.1%.
  • Biggest five-year swings in Operating Margin: skyrocketed 2784bps in 2021 and later plummeted -3889bps in 2022.
  • Lifecore Biomedical, Inc. \De\'s Operating Margin stood at 14.41% in 2021, then plummeted by -270bps to 24.48% in 2022, then surged by 80bps to 4.92% in 2023, then fell by -22bps to 6.02% in 2024, then soared by 343bps to 14.62% in 2025.
  • The last three reported values for Operating Margin were 14.62% (Q2 2025), 25.68% (Q1 2025), and 6.02% (Q4 2024) per Business Quant data.